Clinical Trials Logo

Clinical Trial Summary

Systemic lupus erythematosus (SLE) is a chronic autoimmune and inflammatory disease. The pathogenesis of SLE results from interactions between genes, hormones, and the environment; however, the exact etiology is unknown. SLE can affect many organs and systems, including the musculoskeletal, hematological, renal, neuropsychiatric, cardiovascular and pulmonary systems, and skin. Non-specific general complaints such as malaise, fatigue, arthralgia, anxiety, depression, fever, and weight loss are evident at the onset of the disease and during the activation periods. Patients experience hopelessness due to the complexity of the symptoms and the chronic and progressive nature of the disease, and they experience deterioration in their quality of life due to the interaction of anxiety and depression findings with other symptoms. SLE is a difficult disease to manage because of the different organ and system involvement processes. In addition, these symptoms of the disease and the nature of chronic pain, including central sensitization, cause it to accompany a process that is affected by the mood of the person. Some patients present to a rheumatologist with mild symptoms, while others may present with severe, life-threatening symptoms. The onset of the disease before the age of 18 is defined as childhood onset (juvenile). Childhood-onset SLE accounts for approximately 1/5 of SLE patients. It is known that the main mechanism in the formation of the disease is the production of more than one autoantibody. Although childhood SLE (jSLE) appears to be basically the same disease with similar etiology, pathogenesis, and laboratory findings as in adults, there are differences in the frequency and severity of clinical manifestations. In this respect, the clearest finding is that children with SLE have greater disease severity and earlier disease-related organ damage than adults with SLE. Studies on the disease show that patients with jSLE have not only physical but also cognitive effects. The aim of our study is to examine the effects of exercises applied with a dual-task approach on patients' physical and cognitive status in jSLE cases.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05984316
Study type Interventional
Source Biruni University
Contact eylul pinar kisa
Phone 05321307023
Email eylulpnr93@gmail.com
Status Recruiting
Phase N/A
Start date August 2, 2023
Completion date December 5, 2023

See also
  Status Clinical Trial Phase
Completed NCT05077501 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856 Phase 1
Recruiting NCT04562844 - Assessment and Rehabilitation of Social Cognition in People With Traumatic Brain Injury N/A
Not yet recruiting NCT05490628 - The Effects of Cognitive Rehabilitation on Motor Performance, Balance and Fear of Falling in Stroke Patients N/A
Active, not recruiting NCT05111275 - Cognitive Exercises in Survivors of a Prolonged ICU Stay. N/A
Recruiting NCT05201534 - Interventions in Mathematics and Cognitive Skills N/A
Recruiting NCT05464472 - Impact of Transcatheter Aortic Valve Implantation (TAVI) on Cognitive Functions
Not yet recruiting NCT06357195 - DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Recruiting NCT05886114 - A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China N/A
Withdrawn NCT04019665 - Self-screening of Cognitive Impairment in Primary Care N/A
Completed NCT00240695 - A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment Phase 3
Completed NCT04219774 - NeuroCognition After Carotid Recanalization Phase 2
Not yet recruiting NCT06268080 - Depth of Anesthesia on Postoperative Delirium and Cognitive After Surgery N/A
Completed NCT00695136 - The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism Phase 1/Phase 2
Recruiting NCT04911738 - VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical N/A
Withdrawn NCT01668758 - fMRI and NIRS Imaging for Traumatic Brain Injury N/A
Completed NCT05783830 - Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856 Early Phase 1
Recruiting NCT06186102 - Polyamine Treatment in Elderly Patients With Coronary Artery Disease Phase 2
Recruiting NCT05322031 - The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia Phase 4
Completed NCT04210713 - Neuroimmune Dysfunction in Alcohol Use Disorder Phase 1
Completed NCT05077631 - Study to Evaluate the Effects of Single Ascending Oral Doses of ACD856 on Safety, Tolerability and Pharmacokinetics Phase 1